Results 71 to 80 of about 16,337 (195)
GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES
Sickle cell disease (SCD) and ß-thalassemia represent the most common hemoglobinopathies caused, respectively, by the alteration of structural features or deficient production of the ß-chain of the Hb molecule.
Laura Breda +2 more
doaj +1 more source
Iron Overload: Pathophysiology, Diagnosis and Monitoring
ABSTRACT Iron overload is associated with significant health risks, underscoring the importance of understanding its pathophysiology as well as establishing accurate diagnostic and monitoring methods. Chronic iron overload is associated with either genetic disorders characterized by excessive iron accumulation (hereditary hemochromatosis), or is ...
Elena Chatzikalil +3 more
wiley +1 more source
Background Attention‐deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder marked by persistent patterns of inattention, disorganization, hyperactivity, and impulsivity. Increasing evidence implicates immune‐inflammatory processes in its etiology, with observed associations between ADHD and infectious diseases, allergic ...
Eugene Merzon +11 more
wiley +1 more source
This novel qualitative study provides primary data that reflects the sickle cell service user/carer voice about the changes needed to redefine and integrate nutritional management in standard SCD care. ABSTRACT Introduction Nutrition is not currently integrated into standard care provision in sickle cell disease (SCD) impacting patients experience ...
Claudine Matthews +3 more
wiley +1 more source
IMPORTANCE OF IMPLEMENTING PROGRAM SCREENING NEONATAL HEMOGLOBINOPATHIES IN CAPE VERDE
Hemoglobinopathies are hereditary blood diseases, the most frequent sickle cell anemia. To date not have curative treatment, unless bone marrow transplant, which has yet been carried out experimentally.
Leonel Barbosa Gonçalves
doaj
Background: Hemoglobinopathies are the most commonly inherited red cell disorder around the world. In India, hemoglobinopathies show wide variation of prevalence in different regions and different populations.
Arnab Sinha +2 more
doaj +1 more source
Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency
Rawia F.G. Jensen +4 more
doaj +1 more source
So far, different types of SOX5 variants have been reported in patients with LAMSHF syndrome, which are mainly clustered in the HMG domain. The LAMSHF syndrome has a broad variety of clinical manifestations such as developmental delay, speech delay ...
Akbar Amirfiroozy +4 more
doaj +1 more source
Taiju Utsugisawa, Hitoshi Kanno
openaire +2 more sources

